Equities Research Analysts’ Price Target Changes for September 15th (ABOS, AU, AXR, AZN, BARC, BBNX, BLKB, BNTC, BWIN, CAKE)

Equities Research Analysts’ price target changes for Tuesday, September 15th:

Acumen Pharmaceuticals (NASDAQ:ABOS) had its price target increased by Citigroup Inc. from $4.00 to $5.00. Citigroup Inc. currently has a buy rating on the stock.

AngloGold Ashanti (NYSE:AU) had its target price increased by JPMorgan Chase & Co. from $134.00 to $140.00. They currently have an overweight rating on the stock.

AMREP (NYSE:AXR) had its target price reduced by Freedom Broker from $26.00 to $22.00. Freedom Broker currently has a hold rating on the stock.

AstraZeneca (LON:AZN) had its price target trimmed by Berenberg Bank from £160 to £150. Berenberg Bank currently has a buy rating on the stock.

Barclays (LON:BARC) had its target price boosted by JPMorgan Chase & Co. from GBX 610 to GBX 620. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Beta Bionics (NASDAQ:BBNX) had its price target boosted by Robert W. Baird from $14.00 to $16.00. The firm currently has a neutral rating on the stock.

Blackbaud (NASDAQ:BLKB) had its target price raised by Robert W. Baird from $54.00 to $58.00. They currently have an outperform rating on the stock.

Benitec Biopharma (NASDAQ:BNTC) had its target price increased by Wedbush from $16.00 to $17.00. They currently have an outperform rating on the stock.

Baldwin Insurance Group (NASDAQ:BWIN) had its price target boosted by BMO Capital Markets from $26.00 to $32.50. They currently have a market perform rating on the stock.

Cheesecake Factory (NASDAQ:CAKE) had its target price boosted by Wells Fargo & Company from $90.00 to $105.00. The firm currently has an equal weight rating on the stock.

Cerillion (LON:CER) had its target price trimmed by Deutsche Bank Aktiengesellschaft from GBX 1,400 to GBX 1,200. The firm currently has a buy rating on the stock.

Chime Financial (NASDAQ:CHYM) had its price target increased by The Goldman Sachs Group, Inc. from $33.00 to $37.00. They currently have a buy rating on the stock.

Cellectis (NASDAQ:CLLS) had its target price cut by Wells Fargo & Company from $4.00 to $3.00. The firm currently has an equal weight rating on the stock.

Cellectis (NASDAQ:CLLS) had its target price reduced by Robert W. Baird from $10.00 to $8.00. They currently have an outperform rating on the stock.

CMS Energy (NYSE:CMS) had its price target cut by Jefferies Financial Group Inc. from $78.00 to $74.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.

Contineum Therapeutics (NASDAQ:CTNM) had its target price trimmed by JonesTrading from $26.00 to $24.00. They currently have a buy rating on the stock.

Contineum Therapeutics (NASDAQ:CTNM) had its target price lowered by Robert W. Baird from $20.00 to $19.00. Robert W. Baird currently has an outperform rating on the stock.

GlobalData (LON:DATA) had its target price cut by Berenberg Bank from GBX 105 to GBX 90. The firm currently has a buy rating on the stock.

GlobalData (LON:DATA) had its price target reduced by JPMorgan Chase & Co. from GBX 110 to GBX 90. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Definium Therapeutics (NASDAQ:DFTX) had its target price raised by Robert W. Baird from $75.00 to $79.00. Robert W. Baird currently has an outperform rating on the stock.

Darden Restaurants (NYSE:DRI) had its price target increased by Oppenheimer Holdings, Inc. from $235.00 to $245.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.

Dynatrace (NYSE:DT) had its target price increased by BMO Capital Markets from $60.00 to $62.00. BMO Capital Markets currently has an outperform rating on the stock.

Elmet Group (NASDAQ:ELMT) had its target price increased by Needham & Company LLC from $21.00 to $25.00. The firm currently has a buy rating on the stock.

Enova International (NYSE:ENVA) had its target price reduced by TD Cowen from $257.00 to $220.00. TD Cowen currently has a buy rating on the stock.

Enova International (NYSE:ENVA) had its price target reduced by Citizens Jmp from $270.00 to $215.00. They currently have a market outperform rating on the stock.

Eos Energy Enterprises (NASDAQ:EOSE) had its target price trimmed by Needham & Company LLC from $11.00 to $10.00. The firm currently has a buy rating on the stock.

Flotek Industries (NYSE:FTK) had its target price boosted by Lake Street Capital from $40.00 to $44.00. They currently have a buy rating on the stock.

GSK (LON:GSK) had its price target increased by Berenberg Bank from GBX 2,000 to GBX 2,200. The firm currently has a hold rating on the stock.

Garrett Motion (NASDAQ:GTX) had its target price reduced by JPMorgan Chase & Co. from $37.00 to $35.00. They currently have an overweight rating on the stock.

Hammerson (LON:HMSO) had its price target reduced by Berenberg Bank from GBX 448 to GBX 423. The firm currently has a buy rating on the stock.

Immix Biopharma (NASDAQ:IMMX) had its target price raised by Mizuho from $15.00 to $26.00. The firm currently has an outperform rating on the stock.

Kistos (LON:KIST) had its target price boosted by Berenberg Bank from GBX 325 to GBX 405. Berenberg Bank currently has a buy rating on the stock.

Lloyds Banking Group (LON:LLOY) had its target price increased by JPMorgan Chase & Co. from GBX 121 to GBX 123. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Matador Resources (NYSE:MTDR) had its target price boosted by KeyCorp from $68.00 to $73.00. They currently have an overweight rating on the stock.

NatWest Group (LON:NWG) had its price target boosted by JPMorgan Chase & Co. from GBX 790 to GBX 830. The firm currently has a neutral rating on the stock.

Orchestra BioMed (NASDAQ:OBIO) had its target price raised by B. Riley Financial, Inc. from $10.00 to $11.00. B. Riley Financial, Inc. currently has a buy rating on the stock.

RF Industries (NASDAQ:RFIL) had its target price cut by B. Riley Financial, Inc. from $15.00 to $12.00. The firm currently has a buy rating on the stock.

Solaris Energy Infrastructure (NYSE:SEI) had its target price raised by Needham & Company LLC from $98.00 to $104.00. They currently have a buy rating on the stock.

Sionna Therapeutics (NASDAQ:SION) had its price target raised by Wedbush from $5.00 to $6.00. They currently have a neutral rating on the stock.

Symbotic (NASDAQ:SYM) had its price target lowered by Needham & Company LLC from C$75.00 to C$60.00. The firm currently has a buy rating on the stock.

Teledyne Technologies (NYSE:TDY) had its price target raised by Needham & Company LLC from $750.00 to $760.00. Needham & Company LLC currently has a buy rating on the stock.

Thor Industries (NYSE:THO) had its target price reduced by BMO Capital Markets from $110.00 to $95.00. They currently have an outperform rating on the stock.

Visteon (NASDAQ:VC) had its target price cut by JPMorgan Chase & Co. from $170.00 to $145.00. The firm currently has an overweight rating on the stock.

Vornado Realty Trust (NYSE:VNO) had its price target increased by JPMorgan Chase & Co. from $37.00 to $39.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Wizz Air (LON:WIZZ) had its price target cut by Deutsche Bank Aktiengesellschaft from GBX 1,200 to GBX 1,000. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.

WPP (LON:WPP) had its price target boosted by Berenberg Bank from GBX 405 to GBX 470. They currently have a buy rating on the stock.

Zebra Technologies (NASDAQ:ZBRA) had its target price raised by Needham & Company LLC from $410.00 to $435.00. They currently have a buy rating on the stock.